Literature DB >> 11372592

Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects.

A M Rossi1, M Bianchi, C Guarnieri, R Barale, G M Pacifici.   

Abstract

OBJECTIVE: The aim of the present study was to estimate the concordance rate between erythrocyte thiopurine methyltransferase (TPMT) activity and genotype at the TPMT locus in an Italian population sample.
METHODS: The TPMT phenotype and genotype were determined in an unrelated population of 103 Italian healthy blood donors. Erythrocyte TPMT activity was measured with a radiochemical assay using 12.5 microM S-adenosyl-L-(methyl-14C)-methionine and 4 mM 6-mercaptopurine. The genotyping assay was based on restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) and allele-specific oligonucleotide polymerase chain reaction (ASO-PCR) methods.
RESULTS: All subjects had detectable TPMT activity. The activity of TPMT varied 2.8-fold between the 5th and 95th percentile. This variation was neither age (P = 0.63) nor gender (P = 0.44) regulated and the frequency distribution of TPMT activity is compatible with a polymorphic distribution. The presence of the four most common defective alleles, i.e. TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C, was examined through the entire phenotyped population. Ninety-two subjects did not carry any of the tested mutations. Eleven individuals were heterozygous for one of the mutant alleles and had a TPMT activity lower than 30 pmol/min/mg. Eight subjects were TPMT*1/TPMT*3A, two TPMT*1/TPMT*3C and one was TPMT*1/TPMT*2. The TPMT*3B allele was not detected in the samples analysed.
CONCLUSION: There was a concordance of 97% between genotype and phenotype. All the heterozygotes had an intermediate phenotype. However, the wide variation range in TPMT activity detected in the wild-type homozygotes indicates that other genetic or epigenetic factors influence the TPMT phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372592     DOI: 10.1007/s002280000246

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.

Authors:  Maryam Moini; Fatemeh Ghaderi; Mohamad Mehdi Sagheb; Ali Reza Tavasolli; Negar Azarpira; Masumeh Darai; Bita Geramizadeh
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.

Authors:  Samar I Hamdy; Masahiro Hiratsuka; Kaori Narahara; Naomi Endo; Mervat El-Enany; Nadia Moursi; Mohammed S-E Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

Review 3.  Optimization of conventional therapy in patients with IBD.

Authors:  Kirstin M Taylor; Peter M Irving
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

4.  Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.

Authors:  Nancy Hakooz; Tawfiq Arafat; Debbie Payne; William Ollier; Sudeep Pushpakom; Julie Andrews; William Newman
Journal:  Eur J Clin Pharmacol       Date:  2010-06-03       Impact factor: 2.953

5.  Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks.

Authors:  Hong Wei; Shufeng Zhou; Chengrong Li; Jianping Zhang; Jueheng Wu; Min Huang
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 6.  Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Authors:  Tessa M Bosch; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-06-09

8.  High-resolution melting analysis of the TPMT gene: a study in the Polish population.

Authors:  Marzena Skrzypczak-Zielinska; Pawel Borun; Katarzyna Milanowska; Ludwika Jakubowska-Burek; Oliwia Zakerska; Agnieszka Dobrowolska-Zachwieja; Andrzej Plawski; Ursula G Froster; Marlena Szalata; Ryszard Slomski
Journal:  Genet Test Mol Biomarkers       Date:  2012-12-19

9.  Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.

Authors:  Edna Efrati; Lior Adler; Norberto Krivoy; Eli Sprecher
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

10.  The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease.

Authors:  Laura Chisick; Curtis Oleschuk; Charles N Bernstein
Journal:  Can J Gastroenterol       Date:  2013-01       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.